Calix Director Carl Russo Sells 75,000 Shares at Average Price of $36.20

Transaction Details and Execution Methodology

Carl Russo executed the sale of 75,000 Calix common shares on July 27, 2026, as part of a pre-established trading arrangement. The disclosure filing states that the weighted average sale price across the transaction was $36.1974 per share, with individual sales occurring at prices ranging from $35.795 to $36.74, inclusive. This multi-tranche approach is typical of larger stock dispositions by insiders seeking to minimize market impact while maintaining price efficiency over a trading window.

The filing indicates that these sales were conducted pursuant to a Rule 10b5-1 trading plan that Russo adopted on April 23, 2026. Rule 10b5-1 plans are contractual arrangements allowing company insiders to establish predetermined schedules for selling securities while satisfying affirmative defense conditions that protect against claims of trading on material nonpublic information. The timing of the sale's execution relative to the plan's adoption suggests this was a planned disposition rather than a reactive market move.

Russo's Remaining Ownership Position

Following the 75,000-share sale, the disclosure reveals that Russo continued to maintain substantial beneficial ownership of Calix stock through multiple ownership structures. He directly owned 3,958,037 shares of common stock after the reported transaction. In addition to direct holdings, the filing documents significant indirect ownership through affiliated entities, including approximately 1.57 million shares held by The Crescentico Trust, for which Russo serves as trustee, and 13,782 shares held through Equanimous Investments.

Equanimous Investments is structured with Carl Russo and Tim Pasquinelli as managing members with shared voting and investment power over the entity's holdings. The disclosure notes that both individuals disclaim beneficial ownership except to the extent of their respective pecuniary interests. This multi-layered ownership structure is not uncommon among high-net-worth individuals and company insiders who employ trusts and investment entities for estate planning, tax efficiency, or administrative purposes while maintaining control and economic interest in their securities.

Regulatory Status and Insider Classification

The filing confirms that Carl Russo is subject to Section 16 reporting obligations as both a director and a 10% beneficial owner of Calix Inc. These dual relationships classify him as a "reporting person" under securities law, requiring him to disclose transactions in company securities within specified timeframes. His director status and substantial ownership stake indicate a senior governance role and deep financial commitment to the company's performance and strategic direction.

Russo's position as a 10% owner places him among the company's largest shareholders, which typically gives him influence over major corporate decisions and board-level deliberations. Insider trading disclosures like this one are monitored by institutional investors, securities analysts, and market participants as potential signals of insider confidence or portfolio rebalancing strategies. The fact that Russo retained nearly 4 million shares directly following the sale suggests he maintained substantial exposure to the company's stock performance despite the disposition.

Rule 10b5-1 Plan Framework and Timing

The adoption of a Rule 10b5-1 trading plan on April 23, 2026, more than three months before the July 27 share sale, provides a formal mechanism for Russo to execute predetermined trading in a manner compliant with insider trading regulations. Under Rule 10b5-1(c), insiders who establish binding contracts or plans to trade securities may rely on an affirmative defense to allegations of trading on material nonpublic information, provided they did not possess such information when the plan was adopted and satisfied other statutory conditions.

The existence of such a plan typically signals that the insider has made deliberate financial planning decisions and is executing them according to a schedule established well in advance of actual trading. This reduces perception of opportunistic trading tied to undisclosed corporate developments. The three-month gap between plan adoption and execution, combined with the fact that the sales occurred at prices within a relatively narrow range, suggests an orderly and pre-planned reduction in Russo's equity position rather than a reactive market response.

Share Sale Price Range and Market Context

The filing notes that the 75,000 shares were sold in multiple transactions at prices ranging from $35.795 to $36.74 per share, with the weighted average settlement at $36.1974. This price range represents a relatively tight distribution, spanning approximately 2.7% from the lowest to highest transaction price. The narrow spread suggests that market conditions remained stable during the execution window and that Russo's sell orders were absorbed by the market without significant disruption or price concession.

Investors reviewing insider transactions typically assess the transaction price relative to the stock's recent trading range and historical valuation levels to gauge the insider's confidence in valuation. The filing does not disclose the company's stock price on the filing date or in the days preceding the sale, so the immediate share price impact was not clear from available public information. However, the fact that transactions were executed across multiple price points indicates they were likely distributed over a time period, which is standard practice for larger insider block sales.

Beneficial Ownership Structures and Indirect Holdings

The Crescentico Trust, listed in the filing as holding 1,569,188 shares with Carl Russo as trustee, represents a common estate planning vehicle used by wealthy individuals to hold securities. Trust structures allow for centralized management, potential tax benefits, and orderly succession planning. The indirect nature of this ownership through a trust entity does not diminish Russo's economic interest or influence over voting and investment decisions relating to these shares, but it does provide a formal separation in legal ownership structure.

Equanimous Investments, holding 13,782 shares, involves shared managing membership with Tim Pasquinelli. The disclosure language noting that both individuals disclaim beneficial ownership except to the extent of their pecuniary interest is standard boilerplate in partnership and LLC ownership disclosures, reflecting the fact that each partner's beneficial interest is proportional to their economic stake in the entity. This structure may be employed for co-investment purposes, partnership-based ventures, or consolidated asset management between aligned investors.

Aggregate Beneficial Ownership After the Transaction

When aggregating all beneficial ownership positions disclosed in the filing, Carl Russo's combined shareholding following the July 27 sale totaled approximately 5.54 million shares when combining direct holdings of 3,958,037 shares, the Crescentico Trust's 1,569,188 shares, and Equanimous Investments' 13,782 shares. This combined position underscores the depth of Russo's financial interest in Calix and his substantial stake in the company's future performance and shareholder returns.

The magnitude of retained beneficial ownership, even after the disposition of 75,000 shares, indicates that Russo's sale represented a portfolio rebalancing action rather than a wholesale exit or loss of confidence in the company. Many insiders conduct periodic equity sales for liquidity, diversification, or personal financial management purposes while maintaining core positions in their companies. The retention of roughly 5.54 million shares demonstrates that Russo's long-term economic interests remain heavily aligned with Calix shareholders.

Filing Compliance and Signature Authority

The Form 4 disclosure was filed on July 28, 2026, one day after the transaction execution, which complies with the typical two-business-day filing requirement for insider transactions under current SEC rules. The filing was signed on behalf of Russo by Tom Gemetti, identified as attorney-in-fact, indicating that legal counsel authorized this transaction reporting on behalf of the reporting person. Use of an attorney-in-fact is customary for insider transaction filings and does not alter the legal responsibility or accuracy of the disclosed information.

The filing contains standard statutory language reminding readers that intentional misstatements or omissions of facts in Form 4 filings constitute federal criminal violations under 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). This language underscores the seriousness of insider transaction disclosures and the potential legal consequences for inaccurate reporting. The inclusion of this warning is mandated for all Form 4 filings and reflects the SEC's emphasis on accuracy and transparency in insider trading disclosures.